Dublin, Jan. 15, 2019 (GLOBE NEWSWIRE) -- The "Hemostasis Valve Market by Type (Hemostasis Valve Y Connector, Double Y Connector Hemostasis Valve, One Handed), Application (Angioplasty, Angiography), End User (Hospitals), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The market size for hemostasis valves is expected to reach 175 million by 2023 from USD 132 million in 2018, at a CAGR of 5.8%

The growth in this market is attributed to the increasing number of interventional procedures. Emerging markets will be the key growth hotspots in the hemostasis valves market; a favorable market scenario in these countries will serve to attract a number of players to focus on opportunities there.

The hemostasis valve Y-connectors segment to dominate the market in 2018.

On the basis of type, the hemostasis valves market is segmented into hemostasis valve Y-connectors, double Y-connector hemostasis valves, one-handed hemostasis valves, and other hemostasis valves. In 2018, the hemostasis valve Y-connectors segment is expected to account for the largest share of the hemostasis valves market. The increasing number of interventional procedures worldwide is a key factor driving the growth of this segment.

The angiography segment is estimated to grow rapidly during the forecast period.

On the basis of application, the hemostasis valves market is segmented into two segments, namely, angiography and angioplasty. During the forecast period, the angiography segment is estimated to register the highest growth rate in the overall hemostasis valves market. This growth is mainly due to the increasing number of coronary angiography procedures. With the increasing number of angiography procedures, the demand for hemostasis valves is expected to increase during procedures.

Asia Pacific is estimated to register the highest CAGR during the forecast period.

In this report, the hemostasis valves market is segmented into four major regional segments -North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the increasing number of interventional procedures, the increasing number of hospitals, and the growing geriatric population.

Key players in the hemostasis valves market include Teleflex Incorporated (US), Boston Scientific (US), Abbott (US), B. Braun Melsungen (Germany), DeRoyal Industries, Inc. (US), Freudenberg Medical (US), Argon Medical (US), and Scitech (Brazil).

Key Topics Covered:

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.2 Primary Data
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Hemostasis Valves: Market Overview
4.2 North America: Hemostasis Valves Market, By Application (2018)
4.3 Geographical Snapshot of the Hemostasis Valves Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Interventional Procedures
5.2.2 Opportunities
5.2.2.1 Emerging Economies
5.2.2.2 Growth in the Number of Hospitals

6 Hemostasis Valves Market, By Type
6.1 Introduction
6.2 Hemostasis Valve Y-Connectors
6.2.1 Hemostasis Valve Y-Connectors Segment to Account for the Largest Share of the Hemostasis Valves Market During the Forecast Period
6.3 Double Y-Connector Hemostasis Valves
6.3.1 Double Y-Connector Hemostasis Valves are the Fastest-Growing Segment of the One-Handed Hemostasis Valves Market
6.4 One-Handed Hemostasis Valves
6.4.1 Self-Closing Mechanism of One-Handed Hemostasis Valves to Drive Adoption
6.5 Other Hemostasis Valves

7 Hemostasis Valves Market, By Application
7.1 Introduction
7.2 Angiography
7.2.1 Increasing Number of Coronary Angiography Procedures to Drive Market Growth
7.3 Angioplasty
7.3.1 Increasing Burden of Coronary Heart Disease to Drive Market Growth

8 Hemostasis Valves Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Access to Advanced Facilities and Skilled Personnel is Driving Patient Preference for Hospital Care
8.3 Other End Users

9 Hemostasis Valves Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Rising Target Disease Incidence has Aided the Adoption of New Technologies in the Us
9.2.2 Canada
9.2.2.1 Increasing Number of Pci Procedures
9.3 Europe
9.3.1 Germany
9.3.1.1 Increasing Number of Intervention Procedures
9.3.2 UK
9.3.2.1 Rising Geriatric Population
9.3.3 France
9.3.3.1 Rising Geriatric Population
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 China Will Account for the Largest Share of the APAC Market
9.4.2 India
9.4.2.1 High Prevalence of Target Diseases Will Ensure Demand Growth in India
9.4.3 Japan
9.4.3.1 CVD Mortality has Decreased in the Country
9.4.4 Rest of Asia Pacific
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Market Ranking Analysis, 2017
10.3 Competitive Scenario
10.3.1 Acquisitions
10.3.2 Expansions
10.3.3 Product Launches
10.3.4 Collaborations

11 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/6srsfv/global_hemostasis?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. 

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Valves